Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C., Morris, C., et al. (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England. J Am Heart Assoc, 12, e029423.
Apenteng, P. N., Prieto-Merino, D., Hee, S. W., Lobban, T. C., Caleyachetty, R., & Fitzmaurice, D. A. (2023). Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records. Br J Gen Pract, 73, e816-e824.
Liu, X., Jiang, J., Li, D., Horrow, J., Tamada, H., Kahl, A., et al. (2023). Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom. Cardiol Ther.
Prugger, C., Perier, M. C., Gonzalez-Izquierdo, A., Hemingway, H., Denaxas, S., & Empana, J. P. (2023). Incidence of 12 common cardiovascular diseases and subsequent mortality risk in the general population. Eur J Prev Cardiol.
Rebordosa, C., Plana, E., Rubino, A., Aguado, J., Martinez, D., Lei, A., et al. (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715-1733.
Penner, L. S., Gavan, S. P., Ashcroft, D. M., Peek, N., & Elliott, R. A. (2022). Does co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?. Br J Clin Pharmacol.
Yang, Z., Toh, S., Li, X., Edwards, D., Brayne, C., & Mant, J. (2022). Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis. Eur J Epidemiol.